MIR Medical

What MIR Medical does

MIR - Medical International Research S.p.A. is an Italian privately held medical device company founded in 1993 in Rome, specializing in spirometry and oximetry equipment for respiratory diagnostics. The company develops and manufactures a portfolio that spans professional clinical-grade spirometers (Spirobank II, Spirolab, Minispir), smartphone-compatible personal-use smart devices (SmartOne, Spirobank, Spirodoc), and the Cardionica cardiology product line, all paired with the MIR Spiro software platform offering EMR/EHR integration, cloud connectivity, ATS/ERS 2019-2021 compliance, and a recurring subscription tier (MIR Spiro Platinum). MIR holds internationally recognized patents in spirometry and oximetry technology and has secured major regulatory clearances including FDA, NMPA, ANVISA, COFEPRIS, and Health Canada, enabling distribution in 100+ countries.

The company operates a hybrid go-to-market combining direct online channels (MyMIR portal, Google Play and Apple App Store apps) with a global authorized dealer network and direct sales to healthcare institutions, supported by regional offices and wholly-owned subsidiaries in the USA, France (Lamirau Technologies), and Brazil (Smart Medical Produtos Medico Hospitalares Ltda). Revenue is generated through three streams: one-time hardware device sales, recurring annual software subscriptions via MIR Spiro Platinum, and consumables/accessories. MIR sells to a dual customer base of healthcare professionals and specialists (primary clinical segment) and personal/home users managing respiratory conditions, with a growing emphasis on home monitoring, telemedicine, and public-private healthcare models — exemplified by its integration into the UK NHS governance for virtual spirometry visits and a 2026 strategic partnership with Keva Health for asthma care. Leadership is founder-controlled, with co-founders Paolo Boschetti (CEO/Chairman) and Siro Brugnoli (General Manager) alongside co-CEO Giovanni Carlino heading business development.

Name

MIR Medical

Legal name

MIR - Medical International Research S.p.A.

Website

https://spirometry.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

11–50 employees

Short description

MIR Medical International Research is a Rome-based medical device company founded in 1993 that develops and distributes spirometry, oximetry, and cardiology devices plus the MIR Spiro software platform, serving healthcare professionals and home users across more than 100 countries.

Ownership category

akta.pro rank

Product category

Respiratory Diagnostic Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Software Publishers (5132)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)

akta.pro secondary industry

Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF)

Keywords

• Spirometry medical devices
• Pulse oximetry equipment
• Respiratory diagnostics devices
• Remote patient monitoring
• Cardiology monitoring devices

Headquarters

HQ city

Roma

HQ country

Italy

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Others

Revenue model

1. Medical Device Hardware Sales: Sale of spirometers, oximeters, and cardiology devices for professional and personal use. Products range from clinical-grade diagnostic equipment to smartphone-compatible personal monitoring devices.
2. Software Subscriptions (MIR Spiro Platinum): Annual subscription model for MIR Spiro software providing comprehensive spirometry and oximetry features, EMR/EHR integration, cloud connectivity, interpretation support, and technical support including remote assistance sessions.
3. Accessories and Consumables: Sale of accessories and consumables including non-original turbines and other replacement parts for medical devices.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

MIR - Medical International Research develops and sells medical devices for respiratory diagnostics, including clinical-grade spirometers, pulse oximeters, and a cardiology product line (Cardionica), available in both professional and smartphone-compatible personal-use variants. Devices are paired with the MIR Spiro software platform, which provides EMR/EHR integration, cloud connectivity, and ATS/ERS 2019-2021 compliance, and are sold via direct online channels, an authorized dealer network, and direct enterprise sales to hospitals and clinics worldwide.

Product overview

MIR Medical International Research offers a comprehensive portfolio of medical devices and software for respiratory and cardiac care. The product ecosystem is organized into four main categories: (1) Spirometry and Oximetry — spanning professional clinical spirometers (Spirobank II, Spirolab, Minispir) and smart personal-use devices (SmartOne, Spirobank, Spirodoc) that enable home monitoring and proactive respiratory health management; (2) Cardiology — the Cardionica product line extending cardiovascular monitoring capabilities; (3) Software — MIR Spiro Platinum and MIR Spiro software platforms providing spirometry analysis, EMR/EHR integration, cloud connectivity, and ATS/ERS compliance; and (4) Accessories & Consumables including turbines and spare parts. The portfolio combines professional-grade diagnostic equipment with smartphone-compatible smart devices, facilitating measurement and management of respiratory health beyond hospital settings through home monitoring and telemedicine solutions.

Differentiator

Problem solved

Functional benefit

Brands

• MIR Spiro Platinum: Comprehensive software for spirometry and oximetry with direct EMR/EHR integration, interpretation support, and ATS/ERS 2019-2021 compliance.

Products and services

• MIR Spiro Platinum Annual subscription spirometry and oximetry software with direct EMR/EHR integration, cloud connectivity, interpretation support, offline capability, and ATS/ERS 2019-2021 compliance. A 1-year Platinum subscription is bundled with purchase and includes continuous updates, free technical support, and one remote assistance session. Targeted at healthcare professionals and clinical institutions integrating respiratory diagnostics into EMR workflows.
• MIR Spiro Spirometry and oximetry software platform enabling respiratory function measurement, data management, and clinical evaluation support for healthcare professionals, with EMR/EHR integration and cloud connectivity.
• Cardionica Cardiology product line for cardiac monitoring and assessment, extending MIR's respiratory care portfolio into cardiovascular health management for professional clinical use.
• Spirobank II Professional spirometer line offering clinical-grade spirometry testing with multiple variants (Light, Advanced, Basic, Plus, Smart, Oxi) addressing different clinical settings and user requirements.
• SmartOne Portable wireless spirometer designed for personal use and home monitoring, enabling patients to measure respiratory functions outside clinical settings via smartphone-compatible Smart device technology.
• Minispir Compact handheld spirometry device offering portable diagnostic capabilities for healthcare professionals, combining high-performing spirometry technology in a portable form factor.
• Spirolab Professional spirometry workstation providing comprehensive pulmonary function testing capabilities comparable to diagnostic spirometers and PFT systems for clinical environments.
• Spirotel Telemedicine-enabled spirometry solution supporting remote patient monitoring and virtual healthcare visits, facilitating respiratory health assessment outside traditional clinical environments.
• Spirobank Spirometer product line including Smart and Oxi variants for clinical spirometry and oximetry measurements with smartphone connectivity for clinical and personal health monitoring.
• Spirodoc Wearable oximetry device for continuous monitoring of oxygen saturation levels, supporting both clinical and personal health monitoring applications.
• Accessories & Consumables Spirometer consumables and accessories including turbines and replacement parts used with MIR spirometry and oximetry devices, supporting recurring revenue and ongoing device operation.

Quantifiable outcome

• NHS UK has positively evaluated and integrated MIR's spirometry solutions into its governance for virtual visits implementation

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• Keva HealthcoreStrategic or Co-development Partner · 11 June 2026MIR and Keva Health have partnered to transform asthma care through respiratory monitoring solutions. This strategic partnership combines MIR's spirometry and oximetry expertise with Keva Health's digital health platform to improve asthma management outcomes.
• NHS UK (National Health Service)coreStrategic or Co-development PartnerThe UK's National Health Service has positively evaluated MIR's advancements in technical-medical spirometry and has integrated innovative MIR solutions into its governance, particularly in the implementation of virtual visits for respiratory care.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Vyaire Medical: One of the largest pure-play respiratory diagnostics companies globally, offering spirometry, PFT, ventilation, and consumables. COMPASS-equipped competitor of MIR serving hospitals and pulmonary function labs; significantly larger scale and broader portfolio make it a key incumbent against which MIR must differentiate.
• Masimo: Global leader in pulse oximetry and non-invasive patient monitoring with broad hospital and consumer footprint. Overlaps directly with MIR's oximetry product line (Spirodoc, Spirobank Oxi) but operates across much larger product categories including multiparameter monitoring.

Direct peers

• COSMED: Italy-headquartered manufacturer of spirometry, pulmonary function testing (PFT), and cardiopulmonary diagnostics equipment. Direct competitor in clinical-grade spirometry with overlapping product categories (desktop spirometers, PFT systems, metabolic carts) and similar target customer base of pulmonologists and hospitals worldwide.
• SCHILLER AG: Swiss-based manufacturer of cardiology and spirometry devices with integrated platform offerings. Direct peer in the overlap of cardiology (like MIR's Cardionica line) and respiratory diagnostics, serving hospitals and physician offices globally.
• MGC Diagnostics: US-based cardiopulmonary diagnostics company focused on pulmonary function testing, including PFT systems and related software. Comparable to MIR in product offering and customer segments, with emphasis on hospital-based cardiopulmonary labs.
• nSpire Health: Spirometry and cardiopulmonary diagnostics specialist offering PFT systems, desktop spirometers, and related software. Direct competitor to MIR in clinical and research settings, including ATS/ERS-compliant spirometry platforms.
• Vitalograph: Long-established specialist in spirometry and respiratory diagnostic devices with a portfolio nearly identical to MIR (clinical spirometers, screening devices, consumables). Direct peer competing for the same pulmonology customers with comparable product depth and similar mid-sized enterprise profile.
• NDD Medical Technologies: Swiss maker of EasyOne spirometers, a leading portable and connected spirometry brand. Direct peer in ultrasonic flow-based portable spirometry with smartphone connectivity and cloud platform approach that overlaps strategically with MIR's smart-device strategy for primary care and home use.
• Nonin Medical: Specialist in pulse oximetry and capnography devices with Bluetooth-connected consumer and clinical products. Direct peer in the oximetry segment where MIR competes, with comparable patient and clinician customer segments.

Emerging players

• NuvoAir: Digital respiratory health company combining connected spirometry with virtual care for asthma and COPD patients. Emerging competitor in the home/RPM segment where MIR's smart devices (SmartOne, Spirotel) increasingly compete, particularly relevant given the Keva Health partnership direction.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCILSpO_1MlUBgKcCDiIMhNw
• Facebookfacebook.com/medicalinternationalresearch
• LinkedInlinkedin.com/company/mir-medical
• Instagraminstagram.com/mir_corporate
• Xx.com/mirmedical

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MIR Medical